Modified Posterior Wall Ablation in Persistent Atrial Fibrillation: the BOX-AF Randomized Clinical Trial
Europace · 13.11.2026
DOI: 10.1093/europace/euag318 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Europace, online erschienen am 13.11.2026. Verfasst von Genqing Zhou und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Aims
The efficacy of left atrial posterior wall isolation (PWI) for persistent atrial fibrillation (AF) is controversial. We propose a modified left atrial posterior wall ablation strategy.
Objectives
To evaluate the efficacy and safety of modified posterior wall ablation in patients with persistent AF who underwent first-time radiofrequency catheter ablation. Methods and results In this multicenter, single-blind randomized trial, 276 patients with persistent AF were assigned 1:1 to pulmonary vein isolation (PVI) with (BOX+) or without modified posterior wall ablation (BOX−). Seven participants withdrew, leaving 269 (BOX+, n=139; BOX−, n=130) for primary endpoint analysis. The primary endpoint was freedom from any documented atrial arrhythmia lasting > 30 seconds without antiarrhythmic drugs after a 3 -month blanking period. At 12-month follow-up, the primary endpoint occurred in 120 of 139 patients (86.3%) in the BOX+ group and 113 of 130 (86.9%) in the BOX− group (hazard ratio 1.046, 95% CI, 0.54 - 2.01; P = 0.894). The BOX+ group exhibited longer procedure time and ablation time. Acute successful PWI was achieved in 91 (65.5%) patients assigned to BOX+. In a nonprespecified, post-randomization analysis, arrhythmia-free survival was 93.4% in patients with acute successful PWI, 72.9% in those with attempted but unsuccessful PWI, and 86.9% in controls without attempted PWI (overall log-rank P=0.002). Adverse events were similar between groups.
Conclusion
Routine addition of modified posterior wall ablation did not improve overall outcomes of first-time ablation in persistent AF. However, achieving successful PWI was associated with significantly lower recurrence.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Cardiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Department of Cardiology, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Institute of Cardiovascular Diseases, The First Affiliated Hospital of Dalian Medical University, Dalian, China.
- Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Department of Cardiology, Tianjin Medical University General Hospital, Tianjin, China.
ORCID-Profile: Genqing Zhou, Xiaoyu Wu, Jingbo Li, Yunlong Xia, Zhiyu Lin, Heng Cai, Songwen Chen, Yong Wei, Xiaofeng Lu, Ruhong Jiang, Dongchen Zhou, Xiaomeng Yin, Yuanjun Sun, Chenyang Jiang, Shaowen Liu
Zitieren
APA
Zhou, G., Wu, X., Zheng, L., Li, J., Xia, Y., Lin, Z., Cai, H., Chen, S., Ding, Y., Wei, Y., Lu, X., Huang, D., Jiang, R., Zhou, D., Yin, X., Sun, Y., Jiang, C., & Liu, S. (2026). Modified Posterior Wall Ablation in Persistent Atrial Fibrillation: the BOX-AF Randomized Clinical Trial. Europace. https://doi.org/10.1093/europace/euag318
Vancouver
Zhou G, Wu X, Zheng L, Li J, Xia Y, Lin Z, et al. Modified Posterior Wall Ablation in Persistent Atrial Fibrillation: the BOX-AF Randomized Clinical Trial. Europace. 2026. doi:10.1093/europace/euag318
BibTeX
@article{Zhou2026,
author = {Zhou, Genqing and Wu, Xiaoyu and Zheng, Liangrong and Li, Jingbo and Xia, Yunlong and Lin, Zhiyu and Cai, Heng and Chen, Songwen and Ding, Yu and Wei, Yong and Lu, Xiaofeng and Huang, Dong and Jiang, Ruhong and Zhou, Dongchen and Yin, Xiaomeng and Sun, Yuanjun and Jiang, Chenyang and Liu, Shaowen},
title = {Modified Posterior Wall Ablation in Persistent Atrial Fibrillation: the BOX-AF Randomized Clinical Trial},
journal = {Europace},
year = {2026},
doi = {10.1093/europace/euag318}
}
EUVIMED